Navigation Links
Beckman Coulter Investor Events Second Half of 2008
Date:9/10/2008

ORANGE COUNTY, Calif., Sept. 10 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical tests, announces upcoming company presentations and investor events. Please mark your calendars accordingly.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

-- Q3 2008 Earnings Release scheduled for Tuesday, October 28, 2008. Q3

conference call scheduled for 5:00 p.m. ET.

-- Clinical Lab Tour: Investor Event scheduled for Thursday,

September 25, 2008, in Indianapolis, Indiana. For more information,

contact Beckman Coulter's Investor Relations Department at

(714) 773-7620.

-- Beckman Coulter 2008 Annual Business Review. The executive management

of the company will host one event in New York City, New York, on

Tuesday, December 16, 2008:

-- There will be a live webcast of this event. It will be accessible

through Beckman Coulter's website.

-- The company will attend the following conference:

-- Oppenheimer 19th Annual Healthcare Conference -- Tuesday,

November 4, 2008, in New York City, New York.

-- Lazard Capital Markets Healthcare Conference -- Tuesday,

November 18, 2008, New York City, New York.

-- Piper Jaffray Conference -- Tuesday, December 2, 2008, New York

City, New York.

-- RBC Conference -- Thursday, December 11, 2008, New York City, New

York.

Please refer to the company's website at http://www.beckmancoulter.com for updates on specific details of date and time for the company presentations referenced above. To access this information from our site, select "go to IR" under Investor Relations and look for "What's Ahead".

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represent more than 78% of the company's 2007 revenue of $2.76 billion. For more information, visit http://www.beckmancoulter.com.

Contact: Cynthia Skoglund, (714) 773-8213

Manager, Investor Relations


'/>"/>
SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
2. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
3. Beckman Coulter Announces Second Quarter 2008 Results
4. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
5. Upcoming Beckman Coulter Investor Events Second Half of 2008
6. Beckman Coulter to Present at Upcoming Healthcare Conferences
7. Beckman Coulter Announces First Quarter 2008 Results
8. Beckman Coulter Acquires Rights to Hepatitis C Virus
9. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
10. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
11. Beckman Coulter to Present at the 2008 Bear Stearns London Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... ... Disappearing forests and increased emissions are the main causes of the evolving ... those living in larger cities are affected by air pollution related diseases. , That ... countries globally - decided to take action. , “I knew I had to take ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
(Date:10/9/2017)... ... October 09, 2017 , ... The award-winning American Farmer television series will feature ... Farmer airs Tuesdays at 8:30aET on RFD-TV. , With global population estimates nearing ... how to continue to feed a growing nation. At the same time, many of ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
Breaking Biology News(10 mins):